Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats

Ma, Xue, Meng, Jingru, Jia, Min, Bi, Long, Zhou, Ying, Wang, Yukun, Hu, Jing, He, Gonghao, Luo, Xiaoxing·2013·Journal of Bone and Mineral Research
DOI 10.1002/jbmr.1898

Cited by (200)

Items 101–200 of 200

  1. Impact of prenatal hypoxia on fetal bone growth and osteoporosis in ovariectomized offspring rats
    Yuxian Yang, Xiaorong Fan, Jianying Tao, Ting Xu, Yingying Zhang, Wenna Zhang, Lingjun Li, Xiang Li, Hongmei Ding, Miao Sun et al. · 2018 · Reproductive Toxicology
  2. Interplay between bone and incretin hormones: A review
    Guillaume Mabilleau · 2016 · Morphologie
  3. The effects of Exendin-4 on bone marrow-derived mesenchymal cells
    Paola Luciani, Benedetta Fibbi, Benedetta Mazzanti, Cristiana Deledda, Lara Ballerini, Alessandra Aldinucci, Susanna Benvenuti, Riccardo Saccardi, Alessandro Peri · 2017 · Endocrine
  4. PEGDA/HA mineralized hydrogel loaded with Exendin4 promotes bone regeneration in rat models with bone defects by inducing osteogenesis
    Wei Xin Liu, Xiao-wei Jing, Zhiwen Xu, Chong Teng · 2021 · Journal of Biomaterials Applications
  5. Low Bone Turnover Associates With Lower Insulin Sensitivity in Newly Diagnosed Drug-Naïve Persons With Type 2 Diabetes
    Mohamad I. Nasser, Jacob Volmer Stidsen, Kurt Højlund, Jens Steen Nielsen, Richard Eastell, Morten Frost · 2023 · The Journal of Clinical Endocrinology & Metabolism
  6. Enhanced bone regeneration via endochondral ossification using Exendin-4-modified mesenchymal stem cells
    Zihao He, Hui Li, Yuanyuan Zhang, Shuang Gao, Kaini Liang, Yiqi Su, Du Wang, Zhen Yang, Yanan Du, Dan Xing et al. · 2023 · Bioactive Materials
  7. Dipeptidyl-Peptidase-4 and Glucagon-like-Peptide-1, a Link in the Connection between Periodontitis and Diabetes Mellitus—What Do We Know So Far?—A Scoping Review
    T. Gheonea, Petra Surlin, F. Nicolae, D. Gheorghe, D. Popescu, I. Rogoveanu · 2024 · Journal of Clinical Medicine
  8. Icariin Promotes Fracture Healing in Ovariectomized Rats
    Yong Zhang, Bing Han, Yong Quek Wei, Juehua Jing, Jun Li · 2020 · Medical Science Monitor
  9. Gut-Derived Peptide Hormone Analogues and Potential Treatment of Bone Disorders in Obesity and Diabetes Mellitus
    Asif Ali, Peter R. Flatt, Nigel Irwin · 2024 · Clinical Medicine Insights Endocrinology and Diabetes
  10. Local administration of high-dose diabetes medicine exendin-4 inhibits orthodontic tooth movement in mice
    Wei-Ren Shen, Hideki Kitaura, Jiawei Qi, Saika Ogawa, Fumitoshi Ohori, Takahiro Noguchi, Aseel Marahleh, Yasuhiko Nara, Adya Pramusita, Itaru Mizoguchi · 2020 · The Angle Orthodontist
  11. Risk of fracture caused by anti-diabetic drugs in individuals with type 2 diabetes: A network meta-analysis
    Wen-Hsuan Tsai, Siang-Ke Kong, Chu-Lin Lin, Kai-Hsuan Cheng, Yi-Ting Cheng, Ming-Nan Chien, Chun‐Chuan Lee, Ming-Chieh Tsai · 2022 · Diabetes Research and Clinical Practice
  12. Incretins and bone: friend or foe?
    Guillaume Mabilleau · 2015 · Current Opinion in Pharmacology
  13. Fracture events associated with GLP-1 receptor agonists in FDA adverse events reporting system
    Yao Xiao, Min Zhou, Wenfeng Xiao · 2024 · Acta Diabetologica
  14. GLP-1 receptor agonist use in elective lumbar spine surgery: Reduced pseudarthrosis rates and favorable safety profile
    Sri Tummala, David L. Gibbs, Joseph C. Chavarria, Jason Alder, Ioannis Avramis, James Rizkalla · 2025 · Journal of Orthopaedics
  15. Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study
    Ming Chen, Yiming Lyu, Jingwei Zhao, Xianwei Han, Tao Huang, Tongtao Yang, Yong Zhou · 2025 · Frontiers in Endocrinology
  16. Impact of oral antidiabetic agents on bone metabolism
    Nihal Thomas, ThomasV Paul · 2015 · The Indian Journal of Medical Research
  17. Changes in superoxide dismutase 3 (SOD3) expression in periodontal tissue during orthodontic tooth movement of rat molars and the effect of SOD3 onin vitrohypoxia-exposed rat periodontal ligament cells
    Phanchanit Jindarojanakul, Yukiho Kobayashi, Hiroyuki Kamimoto, Yuki Niki, Aye Chan Myo, Sirichom Satrawaha, Keiji Moriyama · 2023 · European Journal of Orthodontics
  18. Effects of glucagon-like peptide-1 receptor agonists on spermatogenesis-related gene expression in mouse testis and testis-derived cell lines
    Masashi IIDA, Atsushi Asano · 2024 · Journal of Veterinary Medical Science
  19. Beyond Glycemic Control: GLP-1 Receptor Agonists and Their Impact on Calcium Homeostasis in Real-World Patients
    Bandar Theyab Alenezi, Nadra Elfezzani, Rukhsana Uddin, Hinali Patel, Sydney Chester, Ahmed Abdelmaksoud, Mohammad Hosny Hussein, Sawsan A. Zaitone, Manal Said Fawzy, Hani Aiash et al. · 2024 · Journal of Clinical Medicine
  20. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes mellitus: friends or foes to bone health? a narrative review of clinical studies
    Antonella Fardus Al Refaie, Leonardo Baldassini, Caterina Mondillo, Sara Gonnelli, Elena Ceccarelli, Roberto Tarquini, Stefano Gonnelli, Luigi Gennari, Carla Caffarelli · 2025 · Endocrine
  21. Biomarkers of Cellular Senescence in Type 2 Diabetes Mellitus
    Caroline Wei Shan Hoong, Joshua N. Farr, David G. Monroe, Thomas A. White, Elizabeth J. Atkinson, Amanda J. Tweed, Allyson K. Palmer, Nathan K. LeBrasseur, Jad G. Sfeir, Sundeep Khosla · 2025 · Aging Cell
  22. Dipeptidyl peptidase‐4 inhibitors and aerobic exercise synergistically protect against liver injury in ovariectomized rats
    Nagat Younan, Samah Elattar, Mira Farouk Youssef, Laila Ahmed Rashed, Suzanne Estaphan · 2019 · Physiological Reports
  23. Relationship between glucagon-like peptide-1 receptor gene polymorphism and bone mineral density in postmenopausal women in Shanghai
    Lizhi Zhang, Jin‐Wei He, Xiang Ying Sun, Xian Fu Luo, Juli Zeng, Wufeng He, Xiaohui Liu, Bo Feng · 2020 · Annals of Palliative Medicine
  24. Acarbose diminishes postprandial suppression of bone resorption in patients with type 2 diabetes
    Niels B. Dalsgaard, Lærke S. Gasbjerg, Mads Marstrand Helsted, Laura Smidt Hansen, Nina L. Hansen, Kirsa Skov‐Jeppesen, Bolette Hartmann, Jens Juul Holst, Tina Vilsbøll, Filip Krag Knop · 2023 · Bone
  25. Update on: effects of anti-diabetic drugs on bone metabolism
    Guillaume Mabilleau, Béatrice Bouvard · 2020 · Expert Review of Endocrinology & Metabolism
  26. Editorial: Bone: Endocrine Target and Organ
    Giacomina Brunetti, Patrizia D’Amelio, Malgorzata Gabriela Wasniewska, Giorgio Mori, Maria Felicia Faienza · 2017 · Frontiers in Endocrinology
  27. Role of LRP5/6/GSK‐3β/β‐catenin in the differences in exenatide‐ and insulin‐promoted T2D osteogenesis and osteomodulation
    Zijun Chen, Yuxi Wang, Guanhua Zhang, Jian Zheng, Lei Tian, Yingliang Song, Xiangdong Liu · 2024 · British Journal of Pharmacology
  28. The role of glucagon-like peptides in osteosarcopenia
    Enaya Tufail, Somali Sanyal, Ambrish Mithal, Sabyasachi Sanyal, Naibedya Chattopadhyay · 2024 · Journal of Endocrinology
  29. The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential
    Mo Li, Shenghao Xu, Hanqing Cai, Jianlin Xiao, Yanguo Qin · 2026 · Metabolism
  30. Evaluation of Serum Glucagon-Like Peptide 1 and Vitamin D Levels in Elderly Patients with Bone Fractures
    Özhan Pazarcı, Halef Okan Doğan, Seyran Kılınç, Yalkın Çamurcu · 2019 · Medical Principles and Practice
  31. A quinoxaline-based compound ameliorates bone loss in ovariectomized mice
    Ying Jun Zhou, Xiaoyan Xue, Yanyan Guo, Huan Liu, Zheng Hou, Chen Zhou, Ning Wang, Fen Li, Yang Wang · 2021 · Experimental Biology and Medicine
  32. Effect of Liraglutide on Osteoporosis in a Rat Model of Type 2 Diabetes Mellitus: A Histological, Immunohistochemical, and Biochemical Study
    Maha Abdelhamid Fathy, Amal Anbaig, Raja Aljafil, Sherein F. El-sayed, Hanim Magdy Abdelnour, Mona Mostafa Ahmed, Eman M. A. Abdelghany, Sulaiman Mohammed Alnasser, Shaimaa Mohamed Abdelfattah Hassan, Amany Mohamed Shalaby · 2023 · Microscopy and Microanalysis
  33. Incretins Beyond the Pancreas: Exploring the Impact of GIP and GLP-1/2 on Bone Remodeling
    Hejun Zhao, Jie Sun, Zhipeng Ren · 2024 · Discovery Medicine
  34. Short bowel syndrome: influence of nutritional therapy and incretin GLP1 on bone marrow adipose tissue
    Luciana T. Parreiras‐e‐Silva, Iana Mizumukai de Araújo, Jorge Elías, Marcello Henrique Nogueira‐Barbosa, Vívian Marques Miguel Suen, Júlio Sérgio Marchini, Jéssica Bonella, Andressa Kutschenko Nahas, Carlos Ernesto Garrido Salmón, Francisco José Albuquerque de Paula · 2018 · Annals of the New York Academy of Sciences
  35. Activation of GLP-1 receptors enhances the osteogenic differentiation process of STRO-1-positive BMSCs
    Wanlin Zhou, Wenliang Huang, Xiongcheng Shen, Kun Huang, Renyuan Tian, Ye Yuan, Jiang Deng · 2025 · Molecular Biology Reports
  36. Exploring new therapeutic drugs for osteoarthritis and osteoporosis: Glucagon-like peptide-1 receptor agonists: A review
    Mei‐Qi Zheng, Jingjing Zhao, Yuxuan Wang, Zifan Cui, Zihong Qiao, Huaxiang Wu, Chenxia Shi, Xiaofeng Wang · 2025 · Medicine
  37. The hunger games of skeletal metabolism
    Natalie K. Y. Wee, Paul A. J. Baldock · 2014 · BoneKEy Reports
  38. Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models
    Guillaume Mabilleau, Béatrice Bouvard · 2024 · Peptides
  39. Diabetes Medications and Bone
    Andrew B. Grey · 2014 · Current Osteoporosis Reports
  40. GLP-1 and GIP: Magic bullet for musculoskeletal diseases?
    Qihang Fang, Li Gan, Pei Liu, Peng Ding, Youshui Gao · 2025 · Journal of Advanced Research
  41. Short-Term Complications of Preoperative Weight Loss Strategies in Total Knee Arthroplasty: Bariatric Surgery Versus Glucagon-Like Peptide-1 Receptor Agonists
    Aadi Sharma, Brigitte A Lieu, Suhas Rao Velichala, Brady S. Ernst, James R. Satalich, Matthew Smith, Gregory Jason Golladay · 2025 · The Journal of Arthroplasty
  42. Glucagon-Like Peptide 1 Receptor Agonist Use and Vertebral Fracture Risk in Type 2 Diabetes
    Wei-Thing Khor, Kuan-Yu Chi, Hong-Min Lin, Yu‐Sun Chang · 2025 · JAMA Surgery
  43. The Effect of GLP-1 Receptor Agonists on Reoperation Following Anterior Cervical Discectomy and Fusion
    Nicholas C. Bank, Daniel C. Whittingslow, Sam Duggan, Joshua L. Morningstar, Douglas S. Weinberg · 2025 · World Neurosurgery
  44. The enteroendocrine-osseous axis in patients with long-term type 1 diabetes mellitus
    Barbara Katra, Danuta Fedak, Bartłomiej Matejko, Maciej Tadeusz Malecki, Anna Wędrychowicz · 2021 · Bone
  45. How the gut affects bone metabolism
    Marie‐Hélène Lafage‐Proust · 2017 · Joint Bone Spine
  46. Liraglutide in Combination with Insulin Has a Superior Therapeutic Effect to Either Alone on Fracture Healing in Diabetic Rats
    Hao Liu, Faming Tian, Yunpeng Hu, Shao-Hua Ping, Liu Zhang · 2023 · Diabetes Metabolic Syndrome and Obesity
  47. GIPR rs10423928 and bone mineral density in postmenopausal women in Shanghai
    Lizhi Zhang, Jinwei He, Xiang Sun, Dongyue Pang, Jingjing Hu, Bo Feng · 2022 · Endocrine Connections
  48. PCE17 and its active compounds exert an anti-osteoporotic effect through the regulation of receptor activator of nuclear factor-κB ligand in ovariectomized mice
    Hyun‐Ja Jeong, Min Ho Kim, Hyeong-Jin Kim, Hee-Yun Kim, Sun‐Young Nam, Na‐Ra Han, Boyoung Lee, Hosong Cho, Phil‐Dong Moon, Hyung‐Min Kim · 2018 · Journal of Food Biochemistry
  49. Potential effectiveness of exenatide in experimentally-induced osteoporosis
    Osama M. Abu Taleb, Marian Youssry Wissa, Rahma K. Abou El Nour, H A Awad, Nahed M. Moussa · 2019 · The Egyptian Rheumatologist
  50. The GLP-1 analog, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice
    Morgane Mermet, Jessica Denom, Aleksandra Mieczkowska, Méline Wery, Emma K. Biggs, Fiona Mary Gribble, Frank M. Reimann, Chr̀istophe Magnan, Céline Cruciani‐Guglielmacci, Guillaume Mabilleau · 2025 · American Journal of Physiology-Endocrinology and Metabolism
  51. Associations of Semaglutide With Skeletal Outcomes in People With Obesity, With and Without Type 2 Diabetes: A Target Trial Emulation
    Yu‐Nan Huang, Min-Yu Tsou, Pin‐Hung Li, Jo-Ching Chen, Shao-Chia Chen, Hao‐I Hsieh, Gideon Meyerowitz‐Katz, Yen‐Liang Liu, Pen‐Hua Su · 2026 · Diabetes Obesity and Metabolism
  52. Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults
    Jie‐Syuan Wu, Lee‐Yuan Lin, Ji Sun, Wei‐Ting Yu, Fara Silvia Yuliani, Shyh‐Hsiang Lin · 2026 · Obesity
  53. Emerging incretin hormones actions: focus on bone metabolism
    Maria Grammatiki, Vasiliki Antonopoulou, Kalliopi Kotsa · 2019 · Minerva Endocrinology
  54. Discovery and identification of semaphorin 4D as a bioindicator of high fracture incidence in type 2 diabetic mice with glucose control
    Xuanchen Liu, Mo Wang, Bin Xu, Xue Ma, Yangzi Jiang, Hai Xia Huang, Zengzeng Shi, Hao Wu, Zhigang Wu, Shuo Guo et al. · 2025 · Journal of Advanced Research
  55. A biomimetic multimodal nanoplatform combining neutrophil-coated two-dimensional metalloporphyrinic framework nanosheet and exendin-4 to treat obesity-related osteoporosis
    Qifan Yang, Jing Liu, Yanwei Liu, Shun Liu, Xiaokang Wei, Yilin Yang, Weijie Zhang, Shuqi Zhang, Maosheng Zhang, Bin Liu et al. · 2025 · Materials Today Bio
  56. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Diabetes and Obesity: Implications for Periodontology and Family Dentistry
    Asmaa A Almohammad, Sara K Aldossari, Ziyad A Sukumbaji, Raniah A Faden, Mona A Almutairi, Noura H Al-Harbi, Majida Y Al-Saaib, Bandary Almarshedy, Entesar Alharabi, Wafaa A Alhazri et al. · 2025 · Cureus
  57. Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases
    Wenxing Yang, Cong Hao, Ning Wang, Jie Xie, Bin Zhou, Zidan Yang, Aojie Zheng, Jie Wei, Changjun Li, Cen Xie et al. · 2026 · Gut Microbes
  58. Lower fall and femoral fracture risks with semaglutide and tirzepatide compared with DPP-4 inhibitors in older adults with type 2 diabetes
    Hsin-Yu Chen, JM Wu, Yi-Hsin Chu, Tse-Wei Chen, Chun‐Feng Huang · 2026 · Osteoporosis International
  59. Age- and obesity-related metabolic changes and their impact on the incidence of digestion, metabolism, and immune health
    Małgorzata Bukowiecka‐Matusiak, Izabela Burzyńska-Pędziwiatr, Lucyna A. Woźniak · 2022 · Elsevier eBooks
  60. Recent Advances in Promoting Bone Regeneration in Type 2 Diabetes Using Drug Delivery Vehicles and Vehicle‐Free Therapeutics
    Yasamin Pesaran Afsharian, Mostafa Rahimnejad, Sayed Mahmood Rabiee, Farideh Feizi, Hermann Seitz · 2025 · Advanced Therapeutics
  61. Narrative Review of Perioperative Glucagon-like Peptide-1 (GLP-1) Agonists in Spine Surgery
    James W. Connelly, Rajkishen Narayanan, Teeto Ezeonu, Parth Kothari, Nicholas Spina, William Ryan Spiker, Brandon Douglas Lawrence, Darrel Scott Brodke, Gregory Douglas Schroeder, Brian A. Karamian · 2025 · Clinical Spine Surgery A Spine Publication
  62. Polymorphism of glucagon-like peptide-1 receptor gene (rs1042044) is associated with bone mineral density in Chinese Han postmenopausal women
    Suochao Fu, Xu Wen-Mang, Ying Zhang, Zenghui Wu, Xia Hong, He Gong-Hao, Qingshui Yin · 2015 · AFRICAN JOURNAL OF BIOTECHNOLOGY
  63. Impact of Anti-hyperglycemic Medications on Bone Health
    Naim M. Maalouf · 2015 · Clinical Reviews in Bone and Mineral Metabolism
  64. Impacto de la cirugía bariátrica en el tejido óseo
    Sonsoles Botella Martínez, Estrella Petrina Jáuregui, Javier Escalada · 2018 · Endocrinología Diabetes y Nutrición
  65. Endocrine Functions of Bone
    Mathieu Ferron · 2018 · Endocrinology
  66. Exenatide, a glucagon-like peptide-1 receptor agonist, may negatively impact bone healing in rats: histopathological, biochemical, and in silico findings
    Fatih Uğur, İbrahim Yılmaz, Ersin Güner, Mehmet Albayrak, Recep Taşkın, Nurtaç Asa Sarıkaş, Mehmet Akif Bildirici, Ayşe Başak Dellalbaşı, Candemir Özcan · 2025 · Journal of Orthopaedic Surgery and Research
  67. Patients taking GLP-1 agonists for weight-loss prior to posterior lumbar decompression and fusion have similar surgical and patient-reported outcomes
    Joydeep Baidya, Jonathan Dalton, Gregorio Baek, Adam N. Fano, Robert J. Oris, Rachel Huang, Chloe K. Herczeg, Jarod Olson, Mitchell Ng, William A. Green et al. · 2026 · European Spine Journal
  68. Negative effects of semaglutide on bone in obese mice
    K. Eisner, S. Jeromson, Kawkab Tahboub, E. Zimmerman, David C. Wright · 2026 · Cell Reports Medicine
  69. Antidiabetic drugs and their effect on bone
    Peter Jackuliak, Martin Kužma, Juraj Payer · 2017 · Vnitřní lékařství
  70. Endocrine Functions of Bone
    Mathieu Ferron · 2016 · Endocrinology
  71. Impact of bariatric surgery on bone tissue
    Sonsoles Botella Martínez, Estrella Petrina Jáuregui, Javier Escalada San Martín · 2019 · Endocrinología Diabetes y Nutrición (English ed )
  72. Diabetes and bone
    Caterina Conte, Roger Bouillon, Nicola Napoli · 2019 · Elsevier eBooks
  73. Impact of glucose-lowering medications on bone health in diabetes
    Palak U. Choksi, MengHee Tan · 2020 · Elsevier eBooks
  74. Relationship Between GIP Receptor Gene Polymorphism rs10423928 and Bone Mineral Density in Postmenopausal Women in Shanghai
    Lizhi Zhang, Jin‐Wei He, Xiang Ying Sun, Dongyue Pang, Jingjing Hu, Bo Feng · 2020
  75. Role of Lrp5/6-activated Wnt signaling in the promotion of implant osseointegration and regulation of osteogenic & lipogenic induction via exenatide in T2DM rats
    Xiangdong Liu, Zijun Chen, Jian Zheng, Di Wang, Song Ying-liang · 2023 · Research Square
  76. BIOMARCADORES SÉRICOS EM RATOS OSTEOPORÓTICOS JUVENIS PARA A AVALIAÇÃO DO METABOLISMO ÓSSEO
    Doutor Bruno Colaço, Doutor Pedro Gomes · 2014
  77. Comment le tube digestif impacte-t-il le métabolisme osseux ?
    Marie‐Hélène Lafage‐Proust · 2016 · Revue du Rhumatisme Monographies
  78. Einfluss oraler Antidiabetika auf Knochenstoffwechsel und Frakturrisiko
    Cyril Traechslin, Janina Vavanikunnel, MARIUS E. KRAENZLIN, Christian Meier · 2018 · Osteologie/Osteology
  79. Bone and Diabetes
    A. Palermo, A. Naciu, G. Tabacco, L. D'Onofrio, N. Napoli · 2018 · Springer eBooks
  80. Bone Matrix IGF-1 in Bone Remodeling
    Janet L. Crane · 2020 · Elsevier eBooks
  81. Osteoporose bei Diabetes mellitus
    Elena A. Tsourdi, Lorenz Christian Hofbauer · 2021 · Diabetes aktuell
  82. Research Progress on How to Prevent Osteoporosis in Diabetic Patients
    婷玉 牛 · 2022 · Advances in Clinical Medicine
  83. New Drugs for Type 2 Diabetes: New Hopes and New Concerns About the Skeleton
    Zehra Berberoğlu · 2016 · EMJ Oncology
  84. Expression of superoxide dismutase 3 (SOD3) during orthodontic tooth movement in rats
    Phanchanit Jindarojanakul · 2022
  85. Effetti dei nuovi farmaci incretinici sulla salute dell’osso
    Gian Pio Sorice, Mariangela Caporusso, Ludovico Di Gioia, Luigi Laviola, Francesco Giorgino · 2024 · L Endocrinologo
  86. Semaglutide interferes with postnatal development of juvenile mice with compromised growth
    Amélie Joly, Lucas Rebiffé, Yves Dusabyinema, Julien Dellinger, Karine Cécile Gauthier, François Leulier, Filipe De Vadder · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  87. The GLP-1 analogue, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice
    Morgane Mermet, Jessica Denom, Aleksandra Mieczkowska, Emma K. Biggs, Fiona Mary Gribble, Frank M. Reimann, Chr̀istophe Magnan, Céline Cruciani‐Guglielmacci, Guillaume Mabilleau · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Modulation of Bone Turnover Markers with Dipeptidyl Deptidase-4: Interplay in Bone Health
    Faraha Ahmed, Syed Sufian Ahmad, Abul Kalam Najmi, Mohammad Ahmed Khan · 2025 · Current Drug Therapy
  89. GLP-1 Receptor Agonists in Spine Surgery: Current Evidence and Future Directions
    Luis M. Salazar, Samuel P. Alfonsi, Vincent P. Federico, Arash J. Sayari · 2025 · Contemporary Spine Surgery
  90. Osteogenic effects of metformin and exenatide on bone regeneration in non-diabetic rats: A Micro-CT and histological study
    Hasan Ozturk, Neslihan Şımşek, Levent Akıncı, Meltem Özgöçmen, Dilek Helvacıoğlu-Yiğit · 2025 · Journal of Oral and Maxillofacial Pathology
  91. Semaglutide Exacerbates Stunting in Growth-Impaired Juvenile Male Mice via Reduced Energy Metabolism
    Amélie Joly, Lucas Rebiffé, Yves Dusabyinema, Julien Dellinger, Estelle Caillon, Karine Cécile Gauthier, François Leulier, Filipe De Vadder · 2025 · Journal of the Endocrine Society
  92. Impact of Glucagon-Like Peptide-1 Receptor Agonists on Hip Arthroplasty Outcomes: A Systematic Review and Meta-Analysis
    H. Zaffar, M. Imran, Sulaiman Hussain, Farwah Rushd · 2025 · Cureus
  93. Drug Repurposing: Harnessing the Therapeutics from Antidiabetic Molecules
    Archana Bhatta, Priyanka Mahale, Harapriya Baral, D. K. Yuvaraj, Ravinder Kumar Kaundal · 2026 · Springer eBooks
  94. Hormones intestinales et remodelage osseux
    Benoît Gobron · 2020 · theses.fr (ABES)
  95. Trimming the Fat: Does GLP-1 Receptor Agonist Therapy Impact Clinical and Functional Results After Tibial Plateau Fracture Fixation?
    Amelia R. Goldstein, Alexander M. Lashgari, Philipp Leucht, Abhishek Ganta, Sanjit R. Konda, Kenneth A. Egol · 2026 · The Journal of Knee Surgery
  96. G protein-coupled receptor signaling in osteogenic bone mesenchymal stem/stromal cells
    Trevor J. Wolfe, Samantha R. Weaver · 2026 · Frontiers in Cell and Developmental Biology
  97. Effects of the glucagon-like peptide-1 receptor agonist PEG-Loxe on diabetic osteoporosis: A mechanistic study
    Lizhi Zhang, Jingjing Hu, Chunxiao Huang, Xiaoli Gao, Dongyue Pang, Lian Duan · 2026 · Molecular Metabolism
  98. The Pleiotropic Therapeutic Perspectives of GLP-1 and GIP Receptor Agonists in Spinal Cord Injury: A Narrative Review
    Shuhao Zhang, Song Liu, Mi Zhou, Jian Wang, Yue Zhang, Hao Zhong, Guangzhi Ning · 2026 · Molecular Neurobiology
  99. Impact of glucagon-like peptide-1 receptor agonists on bone metabolism
    Vidhu Vadini, Daisy Duan, Kendall F. Moseley · 2026 · The Journal of Clinical Endocrinology & Metabolism
  100. Incretin-Based Therapies and the Associated Impact on Bone Health
    Krzysztof Łupina, Miłosz Bronowski, Natalia Dardzińska, Paulina Jaskulska, Adrian Nowak, Anna Romac, Piotr RÓŻAŃSKI, Jakub Janczura · 2026 · International Journal of Pharmacology